Structural Formula (30ee4705 36a5 4a56 852d 9d76c40668db 01)
Tadalafil Tablet
Product Images NDC 13668-565
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 13668-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (30ee4705 36a5 4a56 852d 9d76c40668db 02)
Figure 2 (30ee4705 36a5 4a56 852d 9d76c40668db 03)
This appears to be a chart or graph displaying blood pressure measurements in mmHg over time (in hours) after taking either Tadalafil 20 mg and doxazosin 8 mg or a placebo and doxazosin 8 mg. The chart seems to show measurements in both standing and supine (lying down) positions. No further information is available.*
Figure 3 (30ee4705 36a5 4a56 852d 9d76c40668db 04)
Figure 4 (30ee4705 36a5 4a56 852d 9d76c40668db 05)
This is a graph illustrating the plasma concentration levels of tadalafil, a medication used to treat erectile dysfunction, at different time points after ingestion. The graph shows three different scenarios: a single 20-mg dose, a single 5-mg dose, and a once-daily 5-mg dose following 5 consecutive days of administration. The concentration levels are measured in micrograms per liter (ug/L). The x-axis represents time in hours, and the y-axis represents the concentration levels.*
Figure 5 (30ee4705 36a5 4a56 852d 9d76c40668db 06)
The text describes a chart or graph showing the change in the total score of IPSS (International Prostate Symptom Score) between a treatment of Tadalafil 5 mg and a placebo. The chart represents 12 weeks of treatment duration.*
Figure 6 (30ee4705 36a5 4a56 852d 9d76c40668db 07)
The text describes the change in IPSS total score, a medical indicator, over a treatment period of 12 weeks with Tadalafil 5 mg and a Placebo. The asterisk marks a significant difference between the two treatments with P<0.01. The graph shows the values at different time points of assessment.*
Figure 7 (30ee4705 36a5 4a56 852d 9d76c40668db 08)
The text represents a table that shows the LS Mean Change from Baseline after 12 and 26 weeks of therapy with TadalafilFinasteride and Placebo/Finasteride. The significance of treatment difference is shown with p-values. However, due to missing values and unclear format, it is difficult to provide a more detailed description.*
Figure 8 (30ee4705 36a5 4a56 852d 9d76c40668db 09)
The text provides information about the change in IPSS (International Prostate Symptom Score) Total Score after using Tadalafil 5mg compared to Placebo. The graph shows a significant improvement in symptoms with Tadalafil, with a p-value of less than 0.01. The duration of treatment was 12 weeks.*
Torrent Logo (30ee4705 36a5 4a56 852d 9d76c40668db 10)
Torrent Logo-pi (30ee4705 36a5 4a56 852d 9d76c40668db 11)
Container Label 2.5 mg (30ee4705 36a5 4a56 852d 9d76c40668db 12)
This text appears to be a medication label for Tadalafil tablets, with a dosage of 25 mg. It provides instructions for storage and dispensing, as well as warnings about usage and possible side effects. The recommended usage and other important information is not available.*
Container Label 5 mg (30ee4705 36a5 4a56 852d 9d76c40668db 13)
This appears to be the packaging label of Tadalafil tablets, a medication that is only available with a prescription. The label warns against splitting the tablets and provides the drug's name and its dose. It also indicates the manufacturer's name and code.*
Container Label 10 mg (30ee4705 36a5 4a56 852d 9d76c40668db 14)
This is a description of a medication named Tadalafil, which is found in a bottle containing 10 grams of medication. It comes in the form of S0Tablets and is labeled with the NOC 1366856730. Additionally, it references an "RN PRGOS" along with "USP". Further instructions include "e i it Tadalafil", and that the medication should not be taken by pregnant women. Finally, it includes a warning that the medication should only be taken with a prescription.*
Container Label 20 mg (30ee4705 36a5 4a56 852d 9d76c40668db 15)
This appears to be a label for a medication bottle. The medication is a 20mg dosage of Hcaf1 USP, with 30 tablets contained in the bottle. The medication contains Tadalafil and is intended to address Sifiosmoetn iR. Dosage instructions are unclear. There is additional information about storage and dosage on the label. The rest of the text is difficult to interpret and may be the serial number or manufacturer details.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
